Provided by Tiger Fintech (Singapore) Pte. Ltd.

Psyence Biomedical Ltd

0.6990
+0.00801.16%
Post-market: 0.71300.0140+2.00%18:41 EDT
Volume:61.27K
Turnover:42.52K
Market Cap:3.16M
PE:0.00
High:0.7115
Open:0.6910
Low:0.6706
Close:0.6910
Loading ...

Psyence Biomed Executes Binding Agreements With Optimi Health Corp.

THOMSON REUTERS
·
10 Dec 2024

Psyence Biomed Executes Binding Agreements with Optimi Health Corp.

GlobeNewswire
·
10 Dec 2024

Psyence Group Enters Into Agreements With Its Nasdaq-Listed Associate, Psyence Biomedical, to Settle Outstanding Obligations

THOMSON REUTERS
·
07 Dec 2024

Wall Street Set to Open Flat Thursday; Initial Jobless Claims Higher Than Expected

MT Newswires Live
·
05 Dec 2024

Psyence Biomedical Boosts Equity to Meet Nasdaq Rules

TIPRANKS
·
04 Dec 2024

Psyence Biomedical Revises Debt-for-Equity Deal

TIPRANKS
·
04 Dec 2024

Psyence Biomed Strengthens Position with Valuable Stake and Trials

TIPRANKS
·
03 Dec 2024

BRIEF-Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress

Reuters
·
03 Dec 2024

Psyence Biomedical issues letter to shareholders

TIPRANKS
·
03 Dec 2024

Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress

THOMSON REUTERS
·
03 Dec 2024

Psyence Biomedical Ltd trading halted, news pending

TIPRANKS
·
26 Nov 2024

Billionaire Israel Englander Bought This High-Yield Dividend Stock Hand Over Fist in Q3. Should You Buy It Too?

Motley Fool
·
25 Nov 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Market Exclusive
·
25 Nov 2024

Psyence Biomedical Receives Nasdaq Extension to Meet Continued Listing Rules

MT Newswires Live
·
20 Nov 2024

BRIEF-Psyence Biomedical Announces Favorable Result Of Nasdaq Listing Qualifications Hearing

Reuters
·
20 Nov 2024

Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing

THOMSON REUTERS
·
20 Nov 2024